Saturday 17 October 2026
Export ILMN’s income statement to Excel — free account
Illumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
262.03
5.90
−2.20%
Follow ILMN
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
40.50 | 43.59 | 51.91 | 47.39 | 80.34 | 72.71 | 0.00 | 0.00 | 0.00 | 23.93 |
Piotroski F-Score |
4 | 7 | 5 | 7 | 5 | 3 | 3 | 5 | 5 | 8 |
P/S ratio |
7.82 | 11.56 | 12.87 | 13.39 | 16.33 | 12.27 | 6.69 | 4.70 | 4.86 | 4.68 |
Altman Z-Score |
7.41 | 9.44 | 10.24 | 12.86 | 13.04 | 8.34 | 2.73 | 3.16 | 3.45 | 4.39 |
P/FCF ratio |
36.93 | 57.64 | 51.49 | 57.22 | 60.26 | 171.33 | 0.00 | 75.27 | 30.05 | 22.19 |
Altman Z″-Score (non-manufacturers) |
5.71 | 6.11 | 6.13 | 7.90 | 7.05 | 4.34 | (0.34) | 1.34 | 0.35 | 3.04 |
Beneish M-Score |
(2.83) | (2.55) | (2.63) | (2.18) | (2.89) | (1.48) | (4.56) | (3.12) | (4.32) | (2.51) |
P/Operating CF |
71.57 | 108.22 | 142.96 | 107.08 | 130.32 | 196.85 | 208.69 | 94.42 | 58.37 | 63.33 |
P/B ratio |
8.26 | 11.57 | 11.15 | 10.28 | 11.27 | 5.17 | 4.65 | 3.68 | 8.95 | 7.47 |
Price to Tangible BV |
14.99 | 17.65 | 15.16 | 13.02 | 14.48 | 147.25 | 409.04 | 102.17 | 22.02 | 14.52 |
EV/Sales |
7.61 | 11.22 | 12.41 | 12.76 | 15.63 | 12.45 | 6.68 | 4.90 | 5.03 | 4.76 |
EV/EBITDA |
24.08 | 38.97 | 37.51 | 37.09 | 62.73 | 352.23 | 0.00 | 0.00 | 0.00 | 19.20 |
EV/Operating CF |
23.43 | 35.27 | 36.23 | 43.02 | 46.87 | 103.41 | 78.10 | 46.18 | 26.29 | 19.16 |
EV/FCF |
35.95 | 55.91 | 49.67 | 54.53 | 57.65 | 173.94 | (402.84) | 78.55 | 31.12 | 22.57 |
Quick Ratio |
2.75 | 3.43 | 2.23 | 6.00 | 3.18 | 1.82 | 0.98 | 1.14 | 1.26 | 1.57 |
Current Ratio |
3.29 | 3.99 | 2.49 | 6.69 | 3.60 | 2.48 | 1.28 | 1.66 | 1.78 | 2.08 |
Net Debt/EBITDA |
(0.66) | (1.20) | (1.37) | (1.83) | (2.84) | 2.23 | 0.15 | (0.68) | (0.56) | (0.13) |
Debt/Assets |
24.71% | 22.67% | 28.70% | 16.21% | 15.61% | 11.14% | 12.14% | 14.73% | 23.64% | 22.43% |
Debt/Equity |
0.47 | 0.43 | 0.52 | 0.26 | 0.25 | 0.16 | 0.23 | 0.26 | 0.63 | 0.55 |
Asset Turnover |
0.60 | 0.58 | 0.55 | 0.50 | 0.43 | 0.40 | 0.33 | 0.40 | 0.53 | 0.67 |
Operating CF/Net income |
1.68 | 1.21 | 1.38 | 1.05 | 1.65 | 0.72 | (0.09) | (0.41) | (0.68) | 1.27 |
Capex/Depreciation |
(1.58) | (1.68) | (1.35) | (0.89) | (0.83) | (0.73) | (1.18) | (0.45) | (0.36) | (0.55) |
Interest Coverage |
17.79 | 16.38 | 15.49 | 18.94 | 11.84 | (2.02) | (160.73) | (13.88) | (8.33) | 7.99 |
| 22.48% | 28.93% | 25.05% | 23.69% | 14.10% | 9.87% | (50.80%) | (18.81%) | (30.13%) | 33.36% | |
| 11.62% | 15.22% | 13.52% | 14.04% | 8.80% | 6.68% | (32.07%) | (10.38%) | (14.90%) | 13.13% | |
ROIC |
20.74% | 21.09% | 23.69% | 25.81% | 15.07% | (0.69%) | (43.18%) | (10.81%) | (19.70%) | 19.55% |
Return on Tangible Assets |
19.91% | 22.94% | 21.96% | 21.43% | 15.77% | 28.82% | (234.38%) | (56.74%) | (60.72%) | 34.51% |
Average Days of Receivables |
57.99 | 54.51 | 56.29 | 59.03 | 54.88 | 52.26 | 53.43 | 59.48 | 61.36 | 71.77 |
Research and Development Expense of Revenue |
21.02% | 19.84% | 18.69% | 18.26% | 21.06% | 26.18% | 28.82% | 30.06% | 26.74% | 22.27% |
Selling, General and Administrative Expense of Revenue |
24.35% | 24.49% | 23.82% | 23.57% | 29.05% | 46.22% | 28.29% | 35.79% | 24.98% | 25.01% |
Intangible Assets out of Total Assets |
0.24 | 0.18 | 0.15 | 0.13 | 0.14 | 0.68 | 0.53 | 0.55 | 0.22 | 0.20 |
Share Based Compensation of Revenue |
5.38% | 5.96% | 5.79% | 5.48% | 5.99% | 16.66% | 7.98% | 8.44% | 8.46% | 6.33% |
Graham Net Nets |
0.02 | 0.01 | 0.03 | 0.04 | 0.03 | (0.03) | (0.07) | (0.08) | (0.06) | (0.03) |
Graham Number |
33.08 | 46.02 | 57.51 | 69.34 | 56.73 | 90.55 | 0.00 | 0.00 | 0.00 | 46.54 |
Earnings Yield |
2.47% | 2.29% | 1.93% | 2.11% | 1.24% | 1.38% | (14.33%) | (5.48%) | (5.74%) | 4.18% |
Free Cash Flow Yield |
2.71% | 1.73% | 1.94% | 1.75% | 1.66% | 0.58% | (0.25%) | 1.33% | 3.33% | 4.51% |
Revenue per Share |
16.31 | 18.85 | 22.67 | 24.10 | 22.03 | 30.17 | 29.20 | 28.51 | 27.50 | 28.02 |
Operating CF per Share |
5.30 | 5.99 | 7.77 | 7.15 | 7.35 | 3.63 | 2.50 | 3.03 | 5.26 | 6.96 |
Capex per Share |
(1.84) | (2.14) | (2.01) | (1.42) | (1.29) | (1.39) | (2.97) | (1.24) | (0.80) | (0.95) |
Free Cash Flow per Share |
3.46 | 3.86 | 5.76 | 5.73 | 6.06 | 2.25 | (0.47) | 1.78 | 4.46 | 6.01 |
Cash per Share |
10.61 | 14.69 | 23.89 | 23.22 | 23.62 | 8.93 | 12.97 | 6.67 | 7.67 | 10.54 |
Shareholders Equity per Share |
15.44 | 18.83 | 26.16 | 31.38 | 31.93 | 71.60 | 42.03 | 36.36 | 14.92 | 17.57 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
15.44 | 18.83 | 26.16 | 31.38 | 31.93 | 71.60 | 42.03 | 36.36 | 14.92 | 17.57 |
Free Cash Flow |
508.00 | 563.00 | 846.00 | 842.00 | 891.00 | 337.00 | (74.00) | 282.00 | 709.00 | 931.00 |
Working Capital |
1,613.00 | 2,234.00 | 2,686.00 | 3,786.00 | 3,239.00 | 1,620.00 | 788.00 | 1,039.00 | 1,199.00 | 1,704.00 |
Capital Expenditures |
(271.00) | (312.00) | (296.00) | (209.00) | (189.00) | (208.00) | (466.00) | (196.00) | (128.00) | (148.00) |
Net Current Asset Value |
307.00 | 472.00 | 1,376.00 | 1,748.00 | 1,592.00 | (1,764.00) | (2,092.00) | (1,757.00) | (1,184.00) | (632.00) |
EV/EBIT |
31.09 | 50.93 | 46.86 | 45.90 | 87.28 | 0.00 | 0.00 | 0.00 | 0.00 | 25.62 |
Capex to Sales |
0.11 | 0.11 | 0.09 | 0.06 | 0.06 | 0.05 | 0.10 | 0.04 | 0.03 | 0.03 |
Price to Operating Income |
31.94 | 52.50 | 48.57 | 48.16 | 91.22 | 0.00 | 0.00 | 0.00 | 0.00 | 25.19 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.24 | 0.20 | 0.20 | 0.26 | 0.25 | 0.28 | 0.36 | 0.43 | 0.43 | 0.36 |
Cash ROIC |
10.39% | 9.25% | 9.04% | 9.14% | 9.53% | 2.45% | (0.73%) | 3.40% | 13.95% | 15.93% |
Accounts Receivable Turnover |
6.26 | 6.95 | 7.21 | 6.52 | 6.11 | 7.98 | 6.95 | 6.41 | 5.95 | 5.47 |
Accounts Payable Turnover |
5.28 | 6.21 | 6.01 | 6.46 | 6.08 | 5.24 | 5.16 | 6.54 | 6.49 | 6.39 |
Inventory Turnover |
2.56 | 2.93 | 2.87 | 2.89 | 2.83 | 3.42 | 3.23 | 3.05 | 2.66 | 2.65 |
Average Days of Payables |
68.81 | 63.07 | 65.01 | 50.54 | 67.64 | 88.32 | 66.34 | 50.81 | 53.39 | 59.47 |
Days of Inventory on Hand |
149.59 | 131.26 | 136.39 | 121.78 | 131.06 | 114.66 | 128.61 | 121.74 | 132.13 | 139.76 |
Average Receivables |
383.26 | 396.00 | 462.50 | 543.50 | 530.00 | 567.50 | 659.50 | 702.50 | 734.50 | 794.50 |
Average Payables |
138.61 | 149.00 | 172.00 | 166.50 | 170.50 | 262.00 | 312.50 | 269.00 | 233.00 | 230.50 |
Average Inventory |
285.39 | 316.50 | 359.50 | 372.50 | 365.50 | 401.50 | 499.50 | 577.50 | 567.00 | 555.50 |
Average Assets |
3,984.37 | 4,769.00 | 6,108.00 | 7,137.50 | 7,450.50 | 11,401.00 | 13,734.50 | 11,181.50 | 8,207.00 | 6,473.50 |
Average Common Equity |
2,059.28 | 2,509.50 | 3,297.00 | 4,229.00 | 4,653.50 | 7,717.00 | 8,669.50 | 6,172.00 | 4,059.00 | 2,548.00 |
Columns are period end dates